Drug-Coated Balloons & Stents: What Drives Performance?
MedTech Unboxed: Presented by Chamfr
There are several critical factors to performance in drug-coated balloons: how effectively the drug reaches the vessel wall, how long it stays there, and when additional vessel support is needed.
In this episode of MedTech Unboxed, Steve talks with Maciej Kusmierczuk, Head of Development Balloon Catheters and Stents at InnoRa GmbH, about the science and engineering behind drug-coated balloons, stents, and emerging scaffold technologies.
They explore InnoRa’s work with paclitaxel and sirolimus coatings, including a high-performance, double-dose drug-coated balloon designed to deliver more drug to the vessel wall and help it remain there longer in complex cases.
Maciej unpacks why drug dose is only one part of performance.
Coating technology, balloon design, material, inflation pressure, and how effectively the drug transfers to the vessel wall can all influence the final result. He also shares the important role of stents when balloon treatment can’t provide enough mechanical support alone.
See how drug-coated balloons, stents, and emerging scaffold technologies can work together to address different vascular treatment needs.
Loading